findmyKOL
Clinical trialNCT00294190CompletedPhase 2Interventional

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

SponsorSCRI Development Innovations, LLCEnrollment38Carcinoma, Small CellSmall Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northeast Arkansas Clinic

    Jonesboro, Arkansas, United States

  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Consultants in Blood Disorders and Cancer

    Louisville, Kentucky, United States

  • Hematology Oncology Life Center

    Alexandria, Louisiana, United States

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan, United States

  • Methodist Cancer Center

    Omaha, Nebraska, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2006
Primary completion
30 Sept 2007
Completion
31 Jul 2009
Last update posted
10 Dec 2012
Registered enrollment
38
Registry id
NCT00294190

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.